Back to results
US 2021/0277474 A1Published application
Methods and compositions for synthetic biomarkers
AssigneeEARLI Inc.
InventorsDavid SUHY, Paul ESCARPE, Cyriac ROEDING, Justin LIN, Alex HARWIG, Shireen RUDINA, Leland Harrison HARTWELL
Life of this patent
Estimating the term…
Abstract
The present disclosure encompasses embodiments of nucleic acids comprising genetic elements which are useful for the detection of diseased cells.
Claims60
A method for generating a profile of a subject's disease, comprising:
- (a) contacting at least one cell of said subject with a plurality of genetic constructs, wherein:
- said plurality of genetic constructs comprises a plurality of disease-activated promoters respectively operably linked to a plurality of barcode molecules or reporter proteins and said plurality of disease-activated promoters drive expression of said corresponding barcode molecules or said reporter proteins in a cell affected by said disease;
- and
- (b) quantifying expression levels of said plurality of barcode molecules or said reporter proteins to generate said profile.
1 more element
60-98. (canceled)
Dependencies are inferred from the claim text.